Tetrahydro<wbr/>curcumin

Tetrahydrocurcumin

CAT N°: 11757
Price:

804.00 683.40

Tetrahydrocurcumin is a metabolite of curcumin (Item Nos. 81025 | 81025.1) that has diverse biological activities, including antioxidant, anti-inflammatory, anti-angiogenic, and anticancer properties.{42115,38854,1467,42397} It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals in a cell-free assay with an EC50 value of 16.8 ?M.{42115} Tetrahydrocurcumin (50 µM) inhibits LPS-induced increases in inducible nitric oxide synthase (iNOS) and COX-2 expression in RAW 264.7 cells.{38854} It also inhibits LPS-induced increases in TNF-? release when used at a concentration of 100 µM and increases in nitric oxide (NO) production and IL-6 levels in a concentration-dependent manner. Tetrahydrocurcumin reduces carrageenan-induced paw edema in rats (ED50 = 20 mg/kg).{1467} It also reduces the formation of neocapillaries and decreases microvascular density as well as VEGF, VEGF receptor 2 (VEGFR2), and hypoxia-inducible factor-1? (HIF-1?) expression in a CaSki cervical cancer nude mouse xenograft model when administered at doses of 100, 300, and 500 mg/kg.{42397}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione
  • Correlated keywords
    • HZIV-81-2 812 HZIV812 Tetrahydro-curcumin diferuloylmethane Tetrahydrodiferuloylmethane Sabiwhite NSC687845 AS-KTC-004 KTC004 ASKTC-004 ASKTC004 anti-cancer oxidant antiinflammatory antiangiogenic COX2 TNF? IL6 VEGFR-2 HIF1? THC lipopolysaccharide (for LPS-induced) turmeric Indian saffron
  • Product Overview:
    Tetrahydrocurcumin is a metabolite of curcumin (Item Nos. 81025 | 81025.1) that has diverse biological activities, including antioxidant, anti-inflammatory, anti-angiogenic, and anticancer properties.{42115,38854,1467,42397} It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals in a cell-free assay with an EC50 value of 16.8 ?M.{42115} Tetrahydrocurcumin (50 µM) inhibits LPS-induced increases in inducible nitric oxide synthase (iNOS) and COX-2 expression in RAW 264.7 cells.{38854} It also inhibits LPS-induced increases in TNF-? release when used at a concentration of 100 µM and increases in nitric oxide (NO) production and IL-6 levels in a concentration-dependent manner. Tetrahydrocurcumin reduces carrageenan-induced paw edema in rats (ED50 = 20 mg/kg).{1467} It also reduces the formation of neocapillaries and decreases microvascular density as well as VEGF, VEGF receptor 2 (VEGFR2), and hypoxia-inducible factor-1? (HIF-1?) expression in a CaSki cervical cancer nude mouse xenograft model when administered at doses of 100, 300, and 500 mg/kg.{42397}

We also advise you